Sun Pharma shares rise after strong Q3 earnings report
Sun Pharmaceutical Industries reported a 16% rise in Q3 net profit to ₹3,369 cr, with total revenue increasing to ₹15,520 cr. The stock surged nearly 4% post-earnings, reflecting positive market sentiment.
after close1 source ↓written by the desknot a recommendation
- following
- 4%
- in consolidated net
- 16% increase
- for Q3 FY2025
- ₹3,369 cr
- revenue rose
- ₹15,520 cr
- YoY
- ₹13,675 cr
Shares of Sun Pharmaceutical Industries surged nearly 4% following a 16% increase in consolidated net profit to ₹3,369 cr for Q3 FY2025. Total revenue rose to ₹15,520 cr, up from ₹13,675 cr YoY. The board also approved an interim dividend of ₹11 per share, indicating strong financial health.
Not investment advice. For informational purposes only.